Anti-OPRK/ OPRK1/ K-OR-1 monoclonal antibody

Anti-OPRK/ OPRK1/ K-OR-1 antibody for FACS & in-vivo assay

Target products collectionGo to OPRK1/OPRK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T60693-Ab-1/ GM-Tg-hg-T60693-Ab-2Anti-Human OPRK1 monoclonal antibodyHuman
GM-Tg-rg-T60693-Ab-1/ GM-Tg-rg-T60693-Ab-2Anti-Rat OPRK1 monoclonal antibodyRat
GM-Tg-mg-T60693-Ab-1/ GM-Tg-mg-T60693-Ab-2Anti-Mouse OPRK1 monoclonal antibodyMouse
GM-Tg-cynog-T60693-Ab-1/ GM-Tg-cynog-T60693-Ab-2Anti-Cynomolgus/ Rhesus macaque OPRK1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T60693-Ab-1/ GM-Tg-felg-T60693-Ab-2Anti-Feline OPRK1 monoclonal antibodyFeline
GM-Tg-cang-T60693-Ab-1/ GM-Tg-cang-T60693-Ab-2Anti-Canine OPRK1 monoclonal antibodyCanine
GM-Tg-bovg-T60693-Ab-1/ GM-Tg-bovg-T60693-Ab-2Anti-Bovine OPRK1 monoclonal antibodyBovine
GM-Tg-equg-T60693-Ab-1/ GM-Tg-equg-T60693-Ab-2Anti-Equine OPRK1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T60693-Ab-1/ GM-Tg-hg-T60693-Ab-2; GM-Tg-rg-T60693-Ab-1/ GM-Tg-rg-T60693-Ab-2;
GM-Tg-mg-T60693-Ab-1/ GM-Tg-mg-T60693-Ab-2; GM-Tg-cynog-T60693-Ab-1/ GM-Tg-cynog-T60693-Ab-2;
GM-Tg-felg-T60693-Ab-1/ GM-Tg-felg-T60693-Ab-2; GM-Tg-cang-T60693-Ab-1/ GM-Tg-cang-T60693-Ab-2;
GM-Tg-bovg-T60693-Ab-1/ GM-Tg-bovg-T60693-Ab-2; GM-Tg-equg-T60693-Ab-1/ GM-Tg-equg-T60693-Ab-2
Products NameAnti-OPRK1 monoclonal antibody
Formatmab
Target NameOPRK1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OPRK1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species OPRK/ OPRK1/ K-OR-1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP001541human OPRK1 Lentivirus plasmid
    ORF Viral VectorvGMLP001541human OPRK1 Lentivirus particle
    ORF Viral VectorpGMLPm004851mouse Oprk1 Lentivirus plasmid
    ORF Viral VectorvGMLPm004851mouse Oprk1 Lentivirus particle


    Target information

    Target IDGM-T60693
    Target NameOPRK1
    Gene ID4986,18387,29335,710783,486951,101094729,540519,100054492
    Gene Symbol and SynonymsK-OR-1,KOP,KOR,KOR-1,KOR1,MSL-1,OPRK,OPRK1,Oprk2,R21
    Uniprot AccessionP41145,P34975,Q2KIP6
    Uniprot Entry NameOPRK_HUMAN,OPRK_RAT,OPRK_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000082556
    Target ClassificationGPCR

    The target: OPRK1, gene name: OPRK1, also named as K-OR-1, KOR, KOR-1, OPRK. This gene encodes an opioid receptor, which is a member of the 7 transmembrane-spanning G protein-coupled receptor family. It functions as a receptor for endogenous ligands, as well as a receptor for various synthetic opioids. Ligand binding results in inhibition of adenylate cyclase activity and neurotransmitter release. This opioid receptor plays a role in the perception of pain and mediating the hypolocomotor, analgesic and aversive actions of synthetic opioids. Variations in this gene have also been associated with alcohol dependence and opiate addiction. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.